Dr. Dhanunjaya (DJ) Lakkireddy MD, MBA shared valuable insights at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a> about a national survey conducted among 146 non-cardiologists and general cardiologists across the U.S. The purpose was to determine their familiarity with symptomatic inappropriate sinus tachycardia (IST) and available treatment options. Although awareness of IST was low, more than half of cardiologists and general practitioners said they encounter IST patients regularly.

We're passionately focused on the continued innovation and science behind our AtriClip® device portfolio. With over 600,000 devices implanted and more than 90 studies, we’re setting the gold standard to surgical LAAE.​

Stop by booth 915 at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a> to see the latest

At AtriCure, we’re passionately focused on the continued innovation and science behind our AtriClip® device portfolio. With over 600,000 devices implanted and more than 90 studies, we’re setting the gold standard to surgical LAAE.​

Stop by booth 915 at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a> to see the latest AtriClip device innovation.

Designed to reduce the risks associated with standard epicardial access techniques, the EPi-Ease™ Device is providing electrophysiologists another option for accessing the pericardium.​
Discover how by visiting us at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a> at booth 915. ​

Important Safety Information:

Today’s CME session at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a> was a valuable opportunity for attendees to dive into the latest evidence and treatment options for patients with both Advanced Afib and heart failure. With a dynamic session and engaging panel discussion, meaningful conversations and insights were

Today’s CME session at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a> was a valuable opportunity for attendees to dive into the latest evidence and treatment options for patients with both Advanced Afib and heart failure. With a dynamic session and engaging panel discussion, meaningful conversations and insights were shared.

Designed to reduce the risks associated with standard epicardial access techniques, the EPi-Ease™ Device is providing electrophysiologists another option for accessing the pericardium.​
Discover how by visiting us at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a> at booth 915. ​

Important Safety Information: <a href="https://okt.to/SHT5OA&quot; target="_blank">https://okt.to/SHT5OA</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=EPeeps&highlightedUpdat…; target='_blank'>#EPeeps</a>​

Visit us at booth 915 to connect with our team of experts at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a> to explore strategies for long-term Afib burden reduction in LSPAF patients with Hybrid AF™ Therapy. Learn about the benefits of LAA exclusion and try our simulation model for hands-on experience.

Welcome to <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a>! Visit us at booth 915 to connect with our team of experts and explore strategies for long-term Afib burden reduction in Advanced Afib patients with Hybrid AF™ Therapy. Learn about the benefits of LAA exclusion — a Class IA recommendation by major societies — and try our simulation model for a hands-on experience.

This week, we met with APPs, Nurses, and HCPs to discuss cardiac ablation techniques, patient selection, and developing a heart team approach to Afib treatment. Thank you to the those who joined us!

Couldn't attend? Register for the next session at: <a href="https://t.co/cHEJKjZqrw&quot; target="_blank">https://t.co/cHEJKjZqrw</a&gt;